Results 141 to 150 of about 51,886 (205)

Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective. [PDF]

Genes (Basel)
Basquiera AL, Andreoli V, Grille S, Belli CB.   +3 more
europepmc   +1 more source

Red blood cell transfusion practice and cardiac comorbidities in patients with myelodysplastic syndromes. [PDF]

Transfusion
Mo A, Wood EM, Shortt J, McQuilten ZK.
europepmc   +1 more source

The Role of Iron-Overloaded Macrophages in Mesenchymal Stem Cell Senescence and Anemia in Myelodysplastic Syndromes: Protocol for an In Vitro Study.

JMIR Res Protoc
Bai L, Wang F, Jiang Y, Ouyang H.
europepmc   +1 more source

Diagnosis of myelodysplastic syndromes: the classic and the novel. [PDF]

Haematologica
Oster HS, Van de Loosdrecht AA, Mittelman M.   +2 more
europepmc   +1 more source

Treatment of lower-risk myelodysplastic syndromes. [PDF]

Haematologica
Merz AMA, Platzbecker U.
europepmc   +1 more source

Impact of iron chelation therapy on mitochondrial function, vascular integrity and inflammation in transfusion-dependent myelodysplastic syndromes. [PDF]

Front Immunol
García-Delgado R, Moreno-Carrasco G, Carrasco-Gomariz M, García-Segovia S, Flores RMO, Torres-González J, Gallego-Fuillerat G, López-Villodres JA, Escamilla-Sánchez A.   +8 more
europepmc   +1 more source

Research progress on ferroptosis in Myelodysplastic syndromes. [PDF]

Front Pharmacol
Yang Y, Han J, Wei Y, Jin J, Feng W.
europepmc   +1 more source

Deciphering clinical features and treatment patterns of thrombocytopenic myelodysplastic syndromes. [PDF]

Ann Hematol
Galli N, Pettine L, Croci G, Passamonti F, Barcellini W, Fattizzo B.   +5 more
europepmc   +1 more source

Treatment of high-risk myelodysplastic syndromes. [PDF]

Haematologica
Kröger N.
europepmc   +1 more source

Implications for metabolic disturbances in myelodysplastic syndromes. [PDF]

Semin Hematol
McGraw KL, Larson DR.
europepmc   +1 more source